STOCK TITAN

[6-K] Medirom Healthcare Technologies Inc. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Medirom Healthcare Technologies Inc. furnished a Form 6-K for October 2025. The filing provides an interim report for the six months ended June 30, 2025 and related Inline XBRL files.

The company states that this Form 6-K, including its exhibits, is incorporated by reference into its Form F-3 registration statement (File No. 333-290161) and will form part of that registration statement unless superseded by later filings.

Medirom Healthcare Technologies Inc. ha presentato una Form 6-K per ottobre 2025. Il documento fornisce un rapporto intermedio per i sei mesi conclusi il 30 giugno 2025 e i relativi file Inline XBRL. L'azienda afferma che questa Form 6-K, inclusi i suoi allegati, è incorporata per riferimento nella sua dichiarazione di registrazione Form F-3 (File No. 333-290161) e costituirà parte di tale dichiarazione di registrazione a meno che non sia sostituita da successive presentazioni.
Medirom Healthcare Technologies Inc. presentó un Form 6-K para octubre de 2025. El archivo proporciona un informe interino para los seis meses terminados el 30 de junio de 2025 y los archivos Inline XBRL relacionados. La empresa afirma que este Form 6-K, incluidos sus anexos, está incorporado por referencia en su declaración de registro Form F-3 (Archivo No. 333-290161) y formará parte de dicha declaración de registro a menos que sea reemplazado por presentaciones posteriores.
Medirom Healthcare Technologies Inc.은 2025년 10월용 Form 6-K를 제출했습니다. 이 제출서는 2025년 6월 30일 종료된 6개월에 대한 중간 보고서와 관련 Inline XBRL 파일을 제공합니다. 회사는 이 Form 6-K(권리 증거 포함)가 Form F-3 등록 서류(파일 번호 333-290161)에 참조로 통합되어 있으며 이후의 제출로 보완되지 않는 한 해당 등록 서류의 일부를 형성한다고 밝힙니다.
Medirom Healthcare Technologies Inc. a déposé un Form 6-K pour octobre 2025. Le dépôt fournit un rapport intérimaire pour les six mois se terminant le 30 juin 2025 et les fichiers Inline XBRL associés. L'entreprise indique que ce Form 6-K, y compris ses pièces jointes, est incorporé par référence dans sa déclaration d'enregistrement Form F-3 (Numéro de fichier 333-290161) et fera partie de cette déclaration d'enregistrement, sauf si des dépôts ultérieurs la remplacent.
Medirom Healthcare Technologies Inc. hat ein Form 6-K für Oktober 2025 eingereicht. Die Einreichung enthält einen Zwischenbericht für die sechs Monate bis zum 30. Juni 2025 und damit verbundene Inline XBRL-Dateien. Das Unternehmen erklärt, dass dieses Form 6-K, einschließlich seiner Anlagen, durch Verweis in seine Form F-3-Registrierungsunterlagen (Datei Nr. 333-290161) aufgenommen wird und Teil dieser Registrierungsunterlage bildet, sofern es nicht durch spätere Einreichungen ersetzt wird.
قدمت Medirom Healthcare Technologies Inc. نموذج 6-K لشهر أكتوبر 2025. يقدّم الملف تقريراً مؤقتاً لمدة الستة أشهر المنتهية في 30 يونيو 2025 والملفات Inline XBRL ذات الصلة. وتذكر الشركة أن هذا النموذج 6-K، بما في ذلك المعروضات الخاصة به، مدمج بالإشارة في بيان التسجيل Form F-3 الخاص بها (رقم الملف 333-290161) وسيشكل جزءاً من ذلك البيان التسجيل ما لم تستبدلها ملفات لاحقة.
Medirom Healthcare Technologies Inc. 已提交截至2025年10月的 Form 6-K。该备案提供截止至2025年6月30日的六个月中期报告及相关的 Inline XBRL 文件。公司表示,该 Form 6-K 及其附件将通过引用并入其 Form F-3 登记声明(档案号 333-290161),并将成为该登记声明的一部分,除非后续备案另有替代。
Positive
  • None.
Negative
  • None.
Medirom Healthcare Technologies Inc. ha presentato una Form 6-K per ottobre 2025. Il documento fornisce un rapporto intermedio per i sei mesi conclusi il 30 giugno 2025 e i relativi file Inline XBRL. L'azienda afferma che questa Form 6-K, inclusi i suoi allegati, è incorporata per riferimento nella sua dichiarazione di registrazione Form F-3 (File No. 333-290161) e costituirà parte di tale dichiarazione di registrazione a meno che non sia sostituita da successive presentazioni.
Medirom Healthcare Technologies Inc. presentó un Form 6-K para octubre de 2025. El archivo proporciona un informe interino para los seis meses terminados el 30 de junio de 2025 y los archivos Inline XBRL relacionados. La empresa afirma que este Form 6-K, incluidos sus anexos, está incorporado por referencia en su declaración de registro Form F-3 (Archivo No. 333-290161) y formará parte de dicha declaración de registro a menos que sea reemplazado por presentaciones posteriores.
Medirom Healthcare Technologies Inc.은 2025년 10월용 Form 6-K를 제출했습니다. 이 제출서는 2025년 6월 30일 종료된 6개월에 대한 중간 보고서와 관련 Inline XBRL 파일을 제공합니다. 회사는 이 Form 6-K(권리 증거 포함)가 Form F-3 등록 서류(파일 번호 333-290161)에 참조로 통합되어 있으며 이후의 제출로 보완되지 않는 한 해당 등록 서류의 일부를 형성한다고 밝힙니다.
Medirom Healthcare Technologies Inc. a déposé un Form 6-K pour octobre 2025. Le dépôt fournit un rapport intérimaire pour les six mois se terminant le 30 juin 2025 et les fichiers Inline XBRL associés. L'entreprise indique que ce Form 6-K, y compris ses pièces jointes, est incorporé par référence dans sa déclaration d'enregistrement Form F-3 (Numéro de fichier 333-290161) et fera partie de cette déclaration d'enregistrement, sauf si des dépôts ultérieurs la remplacent.
Medirom Healthcare Technologies Inc. hat ein Form 6-K für Oktober 2025 eingereicht. Die Einreichung enthält einen Zwischenbericht für die sechs Monate bis zum 30. Juni 2025 und damit verbundene Inline XBRL-Dateien. Das Unternehmen erklärt, dass dieses Form 6-K, einschließlich seiner Anlagen, durch Verweis in seine Form F-3-Registrierungsunterlagen (Datei Nr. 333-290161) aufgenommen wird und Teil dieser Registrierungsunterlage bildet, sofern es nicht durch spätere Einreichungen ersetzt wird.
Medirom Healthcare Technologies Inc.0001819704Q22025false--12-312025-06-3000018197042025-01-012025-06-300001819704us-gaap:AdditionalPaidInCapitalMember2024-01-012024-06-300001819704us-gaap:CommonStockMember2024-01-012024-06-300001819704us-gaap:TreasuryStockCommonMember2025-06-300001819704us-gaap:RetainedEarningsMember2025-06-300001819704us-gaap:NoncontrollingInterestMember2025-06-300001819704us-gaap:AdditionalPaidInCapitalMember2025-06-300001819704us-gaap:TreasuryStockCommonMember2024-12-310001819704us-gaap:RetainedEarningsMember2024-12-310001819704us-gaap:NoncontrollingInterestMember2024-12-310001819704us-gaap:AdditionalPaidInCapitalMember2024-12-310001819704us-gaap:TreasuryStockCommonMember2024-06-300001819704us-gaap:RetainedEarningsMember2024-06-300001819704us-gaap:NoncontrollingInterestMember2024-06-300001819704us-gaap:AdditionalPaidInCapitalMember2024-06-300001819704us-gaap:TreasuryStockCommonMember2023-12-310001819704us-gaap:RetainedEarningsMember2023-12-310001819704us-gaap:NoncontrollingInterestMember2023-12-310001819704us-gaap:AdditionalPaidInCapitalMember2023-12-310001819704mrm:ShortTermDebtWithMaturingMarch312026Memberus-gaap:SubsequentEventMember2025-07-012025-07-010001819704mrm:ShortTermDebtWithMaturingDecember312025Memberus-gaap:SubsequentEventMember2025-07-012025-07-010001819704mrm:Yen266MillionShortTermLoanMember2025-03-312025-03-310001819704mrm:ShortTermLoanWithMaturityOnMarch312026Member2025-03-312025-03-3100018197042025-03-310001819704us-gaap:CommonClassAMemberus-gaap:CommonStockMember2025-06-300001819704us-gaap:CommonClassAMemberus-gaap:CommonStockMember2024-12-310001819704us-gaap:CommonClassAMemberus-gaap:CommonStockMember2024-06-300001819704us-gaap:CommonStockMember2024-06-300001819704us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-12-310001819704us-gaap:CommonStockMember2023-12-310001819704us-gaap:ConvertibleDebtMember2024-10-012024-10-310001819704us-gaap:ConvertibleDebtMember2022-01-012022-12-3100018197042024-01-012024-12-3100018197042029-01-012025-06-3000018197042028-01-012025-06-3000018197042027-01-012025-06-3000018197042026-01-012025-06-3000018197042030-01-012025-06-3000018197042025-07-012025-06-300001819704us-gaap:RoyaltyMembermrm:RelaxationSalonSegmentMember2025-01-012025-06-300001819704us-gaap:ProductAndServiceOtherMembermrm:DigitalPreventativeHealthcareSegmentMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMemberus-gaap:RoyaltyMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMemberus-gaap:FranchisorOwnedOutletMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMemberus-gaap:FranchiseMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMembermrm:SubleaseRevenueMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMembermrm:StaffingServiceRevenueMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMembermrm:OtherFranchiseMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMembermrm:FranchisorOwnedOutletSoldMember2025-01-012025-06-300001819704us-gaap:FranchisorOwnedOutletMembermrm:RelaxationSalonSegmentMember2025-01-012025-06-300001819704us-gaap:FranchisorOwnedOutletMembermrm:LuxuryBeautySegmentMember2025-01-012025-06-300001819704us-gaap:FranchiseMembermrm:RelaxationSalonSegmentMember2025-01-012025-06-300001819704us-gaap:FranchiseMembermrm:LuxuryBeautySegmentMember2025-01-012025-06-300001819704mrm:SubleaseRevenueMembermrm:RelaxationSalonSegmentMember2025-01-012025-06-300001819704mrm:StaffingServiceRevenueMembermrm:RelaxationSalonSegmentMember2025-01-012025-06-300001819704mrm:OtherFranchiseMembermrm:RelaxationSalonSegmentMember2025-01-012025-06-300001819704mrm:FranchisorOwnedOutletSoldMembermrm:RelaxationSalonSegmentMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMember2025-01-012025-06-300001819704mrm:RelaxationSalonSegmentMember2025-01-012025-06-300001819704mrm:LuxuryBeautySegmentMember2025-01-012025-06-300001819704mrm:DigitalPreventativeHealthcareSegmentMember2025-01-012025-06-300001819704us-gaap:RoyaltyMembermrm:RelaxationSalonSegmentMember2024-01-012024-06-300001819704us-gaap:ProductAndServiceOtherMembermrm:DigitalPreventativeHealthcareSegmentMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMemberus-gaap:RoyaltyMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMemberus-gaap:FranchisorOwnedOutletMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMemberus-gaap:FranchiseMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMembermrm:SubleaseRevenueMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMembermrm:StaffingServiceRevenueMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMembermrm:OtherFranchiseMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMembermrm:FranchisorOwnedOutletSoldMember2024-01-012024-06-300001819704us-gaap:FranchisorOwnedOutletMembermrm:RelaxationSalonSegmentMember2024-01-012024-06-300001819704us-gaap:FranchisorOwnedOutletMembermrm:LuxuryBeautySegmentMember2024-01-012024-06-300001819704us-gaap:FranchiseMembermrm:RelaxationSalonSegmentMember2024-01-012024-06-300001819704us-gaap:FranchiseMembermrm:LuxuryBeautySegmentMember2024-01-012024-06-300001819704mrm:SubleaseRevenueMembermrm:RelaxationSalonSegmentMember2024-01-012024-06-300001819704mrm:StaffingServiceRevenueMembermrm:RelaxationSalonSegmentMember2024-01-012024-06-300001819704mrm:OtherFranchiseMembermrm:RelaxationSalonSegmentMember2024-01-012024-06-300001819704mrm:FranchisorOwnedOutletSoldMembermrm:RelaxationSalonSegmentMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMember2024-01-012024-06-300001819704mrm:RelaxationSalonSegmentMember2024-01-012024-06-300001819704mrm:LuxuryBeautySegmentMember2024-01-012024-06-300001819704mrm:DigitalPreventativeHealthcareSegmentMember2024-01-012024-06-300001819704mrm:MediromMotherLabsLoanMember2025-03-182025-03-180001819704mrm:ShortTermLoanWithMaturityOnOctober312025Member2025-06-232025-06-230001819704mrm:UnsecuredShortTermBankLoanMember2025-03-182025-03-180001819704mrm:MediromMotherLabsInc.Membermrm:YasuhiroHayamiMember2024-12-112024-12-110001819704mrm:MediromMotherLabsInc.Membermrm:IsseiHoumanMember2024-12-112024-12-110001819704us-gaap:FranchisorOwnedOutletMember2025-06-300001819704us-gaap:FranchiseMember2025-06-300001819704mrm:InvestorOwnedMember2025-06-300001819704us-gaap:FranchisorOwnedOutletMember2024-12-310001819704us-gaap:FranchiseMember2024-12-310001819704mrm:InvestorOwnedMember2024-12-310001819704us-gaap:RetainedEarningsMember2025-01-012025-06-300001819704us-gaap:NoncontrollingInterestMember2025-01-012025-06-300001819704us-gaap:RetainedEarningsMember2024-01-012024-06-300001819704us-gaap:NoncontrollingInterestMember2024-01-012024-06-300001819704mrm:RepresentativeDirectorMember2025-06-300001819704mrm:KazuyoshiTakahashiMember2025-06-300001819704mrm:RelaxationSalonsMember2025-01-012025-06-300001819704us-gaap:CommonClassAMember2025-01-012025-06-300001819704mrm:CommonSharesMember2025-01-012025-06-300001819704us-gaap:CommonClassAMember2024-01-012024-06-300001819704mrm:CommonSharesMember2024-01-012024-06-300001819704mrm:ShortTermDebtWithMaturingMarch312026Memberus-gaap:SubsequentEventMember2025-07-010001819704mrm:ShortTermDebtWithMaturingDecember312025Memberus-gaap:SubsequentEventMember2025-07-010001819704srt:MinimumMembermrm:JapaneseFinancialInstitutionsUnsecuredBankLoansMember2025-06-300001819704srt:MaximumMembermrm:JapaneseFinancialInstitutionsUnsecuredBankLoansMember2025-06-300001819704mrm:ShortTermLoanWithMaturityOnOctober312025Member2025-06-230001819704mrm:ShortTermLoanWithMaturityOnSeptember302025Member2025-03-310001819704mrm:UnsecuredShortTermBankLoanMember2025-03-180001819704us-gaap:ConvertibleDebtMember2025-06-300001819704us-gaap:ConvertibleDebtMember2024-12-310001819704us-gaap:ProductAndServiceOtherMember2025-01-012025-06-300001819704us-gaap:FranchiseMember2025-01-012025-06-300001819704us-gaap:ProductAndServiceOtherMember2024-01-012024-06-300001819704us-gaap:FranchisorOwnedOutletMember2024-01-012024-06-300001819704us-gaap:FranchiseMember2024-01-012024-06-300001819704us-gaap:SubsequentEventMember2025-07-310001819704us-gaap:CommonStockMember2025-06-300001819704us-gaap:CommonStockMember2024-12-310001819704us-gaap:CommonStockMember2025-06-300001819704us-gaap:CommonClassAMember2025-06-300001819704us-gaap:CommonStockMember2024-12-310001819704us-gaap:CommonClassAMember2024-12-3100018197042023-12-310001819704us-gaap:FairValueMeasurementsRecurringMember2025-06-300001819704us-gaap:FairValueMeasurementsRecurringMember2024-12-310001819704us-gaap:OperatingSegmentsMembermrm:RelaxationSalonSegmentMember2025-06-300001819704us-gaap:OperatingSegmentsMembermrm:LuxuryBeautySegmentMember2025-06-300001819704us-gaap:OperatingSegmentsMembermrm:DigitalPreventativeHealthcareSegmentMember2025-06-300001819704mrm:CorporateAndEliminationsMember2025-06-300001819704us-gaap:OperatingSegmentsMembermrm:RelaxationSalonSegmentMember2024-06-300001819704us-gaap:OperatingSegmentsMembermrm:LuxuryBeautySegmentMember2024-06-300001819704us-gaap:OperatingSegmentsMembermrm:DigitalPreventativeHealthcareSegmentMember2024-06-300001819704mrm:CorporateAndEliminationsMember2024-06-300001819704us-gaap:EmployeeStockOptionMember2025-01-012025-06-300001819704us-gaap:EmployeeStockOptionMember2024-01-012024-06-300001819704us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2024-01-012024-12-310001819704us-gaap:ConvertibleDebtMember2024-10-310001819704us-gaap:ConvertibleDebtMember2022-12-310001819704us-gaap:EmployeeStockOptionMembermrm:DirectorsEmployeesCorporateAuditorsAndOutsideServiceProvidersMemberus-gaap:SubsequentEventMember2025-07-182025-07-180001819704us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2025-01-012025-06-300001819704us-gaap:FairValueMeasurementsNonrecurringMember2025-01-012025-06-300001819704mrm:RepresentativeDirectorMember2025-01-012025-06-3000018197042024-06-300001819704us-gaap:FranchisorOwnedOutletMember2025-01-012025-06-300001819704us-gaap:FranchisorOwnedOutletMember2024-01-012024-12-310001819704mrm:KazuyoshiTakahashiMember2025-01-012025-06-300001819704us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2025-06-300001819704us-gaap:FairValueMeasurementsNonrecurringMember2025-06-300001819704us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2024-12-310001819704us-gaap:FairValueMeasurementsNonrecurringMember2024-01-012024-12-310001819704us-gaap:TrademarksMember2025-06-300001819704us-gaap:OtherIntangibleAssetsMember2025-06-300001819704us-gaap:CustomerRelationshipsMember2025-06-300001819704us-gaap:ComputerSoftwareIntangibleAssetMember2025-06-300001819704mrm:ReacquiredRightsMember2025-06-300001819704us-gaap:TrademarksMember2024-12-310001819704us-gaap:OtherIntangibleAssetsMember2024-12-310001819704us-gaap:CustomerRelationshipsMember2024-12-310001819704us-gaap:ComputerSoftwareIntangibleAssetMember2024-12-310001819704mrm:RepresentativeDirectorMemberus-gaap:CommonStockMember2025-06-300001819704mrm:RepresentativeDirectorMemberus-gaap:CommonClassAMember2025-06-300001819704us-gaap:OperatingSegmentsMembermrm:RelaxationSalonSegmentMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMembermrm:LuxuryBeautySegmentMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMembermrm:DigitalPreventativeHealthcareSegmentMember2025-01-012025-06-300001819704mrm:CorporateAndEliminationsMember2025-01-012025-06-300001819704us-gaap:OperatingSegmentsMembermrm:RelaxationSalonSegmentMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMembermrm:LuxuryBeautySegmentMember2024-01-012024-06-300001819704us-gaap:OperatingSegmentsMembermrm:DigitalPreventativeHealthcareSegmentMember2024-01-012024-06-300001819704mrm:CorporateAndEliminationsMember2024-01-012024-06-3000018197042024-01-012024-06-300001819704mrm:IsseiHoumanMember2024-06-302024-06-3000018197042025-06-3000018197042024-12-31mrm:segmentiso4217:JPYxbrli:puremrm:itemmrm:storemrm:buildingmrm:loanmrm:subsidiaryxbrli:sharesiso4217:JPYxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934

For the month of October 2025

MEDIROM HEALTHCARE TECHNOLOGIES INC.

Commission File Number 001-39809

(Translation of registrant’s name into English)

2-3-1 Daiba, Minato-ku
Tokyo 135-0091, Japan
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F Form 40-F

EXPLANATORY NOTE

This current report on Form 6-K, including the exhibits hereto, is incorporated by reference into the Registration Statement on Form F-3 (File No. 333-290161) and shall be a part of such registration statement from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

Exhibit Index

Exhibit No.

    

Description

99.1

Interim report of MEDIROM Healthcare Technologies Inc. for the six months ended June 30, 2025

101.INS

Inline XBRL Instance Document-this instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 21, 2025

By:

/s/ Fumitoshi Fujiwara

 

Name:

Fumitoshi Fujiwara

 

Title:

Chief Financial Officer

FAQ

What did Medirom (MRM) file?

A Form 6-K furnishing an interim report for the six months ended June 30, 2025, plus Inline XBRL exhibits.

How does this 6-K affect Medirom’s Form F-3?

The 6-K, including exhibits, is incorporated by reference into Form F-3 (File No. 333-290161) and becomes part of that registration statement.

What period does the interim report cover for MRM?

The six months ended June 30, 2025.

Which exhibits accompany the filing?

Exhibit 99.1 (interim report) and Inline XBRL documents (schema, calculation, definition, label, presentation) and the cover page data file.

Is Medirom a foreign private issuer?

Yes. The filing is a Form 6-K report of a foreign private issuer.

What is the SEC file number for Medirom’s F-3?

333-290161.

Who signed the filing for Medirom?

Fumitoshi Fujiwara, Chief Financial Officer.

Medirom Healthcare Technologies Inc

NASDAQ:MRM

MRM Rankings

MRM Latest News

MRM Latest SEC Filings

MRM Stock Data

19.20M
5.81M
26.42%
1.43%
6.28%
Personal Services
Consumer Cyclical
Link
Japan
Tokyo